374Water (SCWO) - 2025 Q3 - Earnings Call Presentation
2025-11-12 21:30
Business Overview - 374Water's AirSCWO system is designed to destroy organic wastes and produce safe water, mineral effluents, vent gas, and recoverable heat energy[8] - The company estimates a $450 billion+ global addressable market, driven by new EPA regulations[8] - The company plans to establish Waste Destruction Services (WDS) at a RCRA Part B TSDF in mid-2026[8] Operational Highlights - 374Water completed a Department of Defense (DoD) project in Detroit, Michigan, with Arcadis and Clean Earth, aimed at identifying commercial-scale technology solutions to destroy PFAS contaminated wastes[9] - The company is preparing for AirSCWO system deployment to Orange County Sanitation (OC San) in Fountain Valley, CA, targeting a late Q4 2025 or early Q1 2026 start-up[9] - 374Water entered into an agreement for the sale and deployment of an AirSCWO 6 system with Olathe, Kansas[9] - The company began processing the first phase of its award by the State of North Carolina to destroy up to 29,000 gallons of Aqueous Film Forming Foam (AFFF) using AirSCWO technology[9] - The company fortified its balance sheet with a new at-the-market facility, resulting in gross proceeds of approximately $7 million, extending cash runway into the second quarter of 2026[9] Financial Performance - For the three months ended September 30, 2025, 374Water reported revenue of $0.8 million, compared to $0.08 million in 2024[20] - Gross profit for the same period was $0.2 million in 2025, compared to a deficit of $0.04 million in 2024[20] - Cash and cash equivalents as of September 30, 2025, were $0.9 million, compared to $10.7 million as of December 31, 2024[20] Future Projections - 374Water projects revenue in the range of $6-8 million for 2026[24] - The company anticipates sales/lease/WDS to be in the range of $10-12 million in 2027, increasing to $15-20 million in 2028, and $25-30 million in 2029/2030[21]
Electromed (NYSEAM:ELMD) Earnings Call Presentation
2025-11-12 21:00
Electromed, Inc. Investor Presentation November 12, 2025 NYSE American: ELMD Innovation Leader in Airway Clearance Technologies Investor Presentation | 2 Electromed – Who We Are Electromed, Inc. is a growing medical device company focused on airway management to help people around the world breathe better, stay healthier, and lead active and fulfilling lives. *As of and for 12 months ended 9/30/2025 Key Stats: Headquarters: New Prague, MN Ticker: ELMD Established: 1992 Annual Revenue: $66.2M* Market Cap: $2 ...
Regal Rexnord (NYSE:RRX) FY Earnings Call Presentation
2025-11-12 18:00
Company Overview - Regal Rexnord's total revenue is approximately $5.9 billion[5] - The adjusted gross margin is around 38%[5] - The company has approximately 30,000 associates[6] Segment Performance - Power Efficiency Solutions (PES) generates ~$2.6 billion in sales with an adjusted gross margin of ~42% and an adjusted EBITDA margin of ~26%[5] - Industrial Powertrain Solutions (IPS) generates ~$1.6 billion in sales with an adjusted gross margin of ~40% and an adjusted EBITDA margin of ~22%[5] - Automation & Motion Control (AMC) generates ~$1.6 billion in sales with an adjusted gross margin of ~30% and an adjusted EBITDA margin of ~16%[5] Growth Verticals - Discrete Automation accounts for approximately 20% of sales[12] - Aerospace accounts for approximately 6% of sales[12] - Medical accounts for approximately 3% of sales[12] - Data Center accounts for approximately 3% of sales[12] Data Center Wins - Automation & Motion Control secured an $80 million order for switchgear[31] - Automation & Motion Control secured a $35 million order[31] - Power Efficiency Solutions secured a $20 million order for HVAC chiller components[33] Robotics Market - Recent wins in the robotics sector are worth approximately $30 million, with a growing backlog[23] - The opportunity funnel in robotics is worth approximately $100 million[23] Aerospace Market - The company estimates a $220,000 ship set potential per plane in the Advanced Air Mobility (AAM) market[27] Data Center Market - The E-POD bid pipeline is greater than $400 million and growing[36] - The data center market is estimated to be around $10 billion[36] Financial Outlook - The company is trading at a Free Cash Flow (FCF) yield of approximately 7%[44]
Hyliion (HYLN) - 2025 Q3 - Earnings Call Presentation
2025-11-12 16:00
Financial Performance - Hyliion reported $0.8 million in R&D service revenue for Q3 2025, compared to $0.0 in Q3 2024[15] - Cost of sales for Q3 2025 was $(0.8) million, compared to $0.0 in Q3 2024[15] - Net loss for Q3 2025 was $(13.3) million, compared to $(11.2) million in Q3 2024[15] - Year-to-date R&D service revenue reached $2.8 million in 2025, up from $0.0 in 2024[15] - Year-to-date net loss was $(44.0) million in 2025, compared to $(37.7) million in 2024[15] - The company ended Q3 with $164.7 million in cash and investments[22] KARNO Power Module and Customer Deployments - Nearly 500 KARNO cores are under non-binding Letters of Intent (LOIs)[12] - Multiple customer units are currently operating at Hyliion's facility[7] - Additional early customer units are slated for completion in 2025 and early 2026[7] - A multi-megawatt navy vessel will be outfitted with initial KARNO units in 2026[10] Outlook - Product commercialization remains on track for 2026[7] - Total cash use for 2025 is estimated at $65 million[22]
Hudbay Minerals(HBM) - 2025 Q3 - Earnings Call Presentation
2025-11-12 16:00
Financial Performance - Adjusted EBITDA for Q3 2025 was $143 million[12], impacted by production deferrals and delayed sales shipments[12] - Adjusted EPS for Q3 2025 was $003 per share[12] - Free cash flow for the last twelve months (LTM) was $309 million[23] - Cash and cash equivalents stood at $611 million in Q3 2025[23] - Net debt to adjusted EBITDA ratio was 05x[23] Production and Operations - Q3 2025 copper production was 242 kt[12] - Q3 2025 gold production was 536 koz[16] - Peru operations copper production was 18 kt in Q3 2025[30], with gold production at 26 koz[30] and cash cost at $130/lb[30] - Manitoba operations gold production was 22 koz in Q3 2025[36], with copper production at 08 kt[36] and gold cash cost at $379/oz[36] - British Columbia operations copper production was 52 kt in Q3 2025[41], with gold production at 48 koz[41] and cash cost at $321/lb[41] Copper World Project - Mitsubishi will contribute $600 million for a 30% JV interest in the Copper World project[47] - Hudbay's estimated equity contribution to the Copper World project is reduced to approximately $200 million[52] - The Copper World project is expected to increase consolidated copper production by +50%[66], adding 92ktpa of copper production[67]
TransDigm(TDG) - 2025 Q4 - Earnings Call Presentation
2025-11-12 16:00
Financial Performance - Q4 FY2025 - Revenue increased by 115% to $2437 million compared to $2185 million in Q4 FY2024[14] - EBITDA As Defined increased by 149% to $1320 million compared to $1149 million in Q4 FY2024[14] - Adjusted EPS increased by 101% to $1082 compared to $983 in Q4 FY2024[14] Financial Performance - Full Year 2025 - Revenue increased by 112% to $8831 million compared to $7940 million in FY2024[16] - EBITDA As Defined increased by 141% to $4760 million compared to $4173 million in FY2024[16] - Adjusted EPS increased by 98% to $3733 compared to $3399 in FY2024[16] Fiscal Year 2026 Outlook - Revenue is projected to be between $9750 million and $9950 million[17, 20] - EBITDA As Defined is projected to be between $5075 million and $5225 million, representing 521% to 525% of sales[20] - Adjusted EPS is projected to be between $3649 and $3853[20] Market Growth Assumptions for FY2026 - Commercial OEM is expected to grow in the high single-digit to mid-teens percentage range[17] - Commercial Aftermarket is expected to grow in the high single-digit percentage range[17] - Defense is expected to grow in the mid-single-digit to high single-digit percentage range[17]
EyePoint Pharmaceuticals (NasdaqGM:EYPT) 2025 Earnings Call Presentation
2025-11-12 15:40
Stifel 2025 Healthcare Conference November 12, 2025 Jay Duker, MD President and CEO © 2025 EyePoint. All Rights Reserved. Legal Disclaimers Various statements made in this presentation are forward-looking, within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, and are inherently subject to risks, uncertainties and potentially inaccurate assumptions. All statements that address activities, events or developments that we intend, expect, plan or believe may occur in the future, are fo ...
Adecoagro S.A.(AGRO) - 2025 Q3 - Earnings Call Presentation
2025-11-12 15:00
Financial Performance - Adecoagro's gross revenues for 3Q25 were $323 million, a decrease of 29% compared to the same period last year[14] - Gross revenues for 9M25 reached $1,039 million, a decrease of 6% compared to the same period last year[14] - Adjusted EBITDA for 3Q25 was $115 million, a 4% increase compared to the same period last year[14] - Adjusted EBITDA for 9M25 was $206 million, a decrease of 39% compared to the same period last year, this includes one-off expenses of $9.2 million from Tether's tender offer[14, 15] Business Segment Highlights - **Sugar, Ethanol & Energy:** Quarterly crushing record was achieved, with a shift towards ethanol production due to greater cane availability[12] - Sugar production decreased by 16% in 3Q25 to 255,563 tons and 21% in 9M25 to 518,381 tons[27] - Ethanol production increased by 42% in 3Q25 to 216,113 m3 and 3% in 9M25 to 445,553 m3[28] - **Farming:** The company is reducing planted area and improving crop mix to enhance future margins[11] - **Rice:** Global prices for long-grain white rice are declining, leading to a reduction in planted area and an increased focus on premium varieties[11] - **Dairy:** Cow productivity and industrial volume reached record levels, with a focus on fluid milk production for the domestic market[11] Capital Allocation and Debt - Net debt evolution as of 3Q25 is $872 million[64] - The company made a $96 million initial down payment for the acquisition of Nutrien's 50% stake in Profertil[62] - $45.2 million was distributed to shareholders, including $35 million in cash dividends ($0.35 per share) and $10.2 million in share repurchases (1.1 million shares at an average price of $9.65 per share)[69]
Loar Holdings Inc.(LOAR) - 2025 Q3 - Earnings Call Presentation
2025-11-12 15:00
Financial Performance & Outlook - Q3 2025 net sales increased by 22.4% to $126.715 million compared to Q3 2024[31] - Adjusted EBITDA for Q3 2025 grew by 28.9% to $49.106 million, with an Adjusted EBITDA Margin of 38.7%[31] - The revised full year 2025 outlook projects net sales between $487 million and $495 million, with an Adjusted EBITDA Margin of approximately 38.0%[46] - The full year 2026 outlook anticipates net sales between $540 million and $550 million, with an Adjusted EBITDA Margin of around 39%[48] - The company anticipates a Free Cash Flow Conversion rate of 125%+ for both YTD 2025 and the full year 2026 outlook[53] Market & Growth Drivers - The company expects 1%-3% annual revenue growth through share gains, innovation, and new product introductions[19] - Commercial OEM is expected to have low-double digit growth in 2026[50] - Commercial Aftermarket is expected to have low-double digit growth in 2026[50] - Defense is expected to have mid-single digit growth in 2026[50]
AFC Gamma(AFCG) - 2025 Q3 - Earnings Call Presentation
2025-11-12 15:00
Company Overview - Advanced Flower Capital (AFCG) is a Nasdaq-listed commercial mortgage REIT providing institutional loans to state law-compliant cannabis operators in the United States[12] - The company aims for attractive risk-adjusted returns with a target average portfolio gross yield of 12%-20%[12][13] - Shareholders approved the plan to convert from a REIT to a BDC, with over 61% of outstanding shares voted and approximately 94% of those votes cast in favor[12] Market Opportunity - The U S legal cannabis market is expected to reach $63 billion by 2030, with a total economic impact surpassing $200 billion[25] - Cannabis market is projected to grow at a CAGR of approximately 12% from 2025 to 2030, outpacing growth projections for wine, spirits, tobacco, and beer[28][31] - 42 states and DC have legalized medical cannabis, with 24 states and DC legalizing adult-use cannabis[32] Portfolio and Deal Flow - AFC's loan portfolio includes 14 loans to borrowers across 16 states[19] - The company has a deal selectivity of 34% since inception[42] - Total closed deals since inception amount to $930 million[42] - The company has sourced $261 billion in total deals since inception[42] - Current commitments stand at $340 million, with a principal balance of $328 million[42] Financial Performance - For the three months ended September 30, 2025, the company reported a net loss of $1249 million[54] - Distributable earnings for the three months ended September 30, 2025, were $354 million, or $016 per basic weighted average share[55] - For the nine months ended September 30, 2025, the company reported a net loss of $2159 million[54] - Distributable earnings for the nine months ended September 30, 2025, were $1147 million, or $052 per basic weighted average share[55]